By Bea Perks
Complex regulation and governance of clinical research in the UK has held back research with no evidence of improved patient safety, concludes a report by the country’s Academy of Medical Sciences (AMS).
The AMS was commissioned by the UK government in March 2010 to review the regulation of clinical and health research. The review, released on 10 January, recommends the establishment of an independent Health Research Agency (HRA) to simplify approval processes that currently differ across the UK. The authors also recommend the establishment of a National Research Governance Service within the HRA to accelerate approval of multicenter studies. The branch would take responsibility for certain approvals of multicenter trials; the current system requires multiple approvals carried out by different units within the country’s National Health Service.
(Click here to continue reading.)
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research